| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |